NEW YORK (GenomeWeb) – Celgene has given the Myeloma Institute at the University of Arkansas for Medical Sciences $10 million to create the Bart Barlogie Center for Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics, the university announced on Monday.

Since the myeloma program at UAMS was founded in 1989, the school has seen more than 11,000 patients and performed more than 9,000 peripheral blood stem cell transplants, UAMS said. It further noted that since 2001, the number of myeloma survivors has increased by 57 percent. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.